These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 1348433)

  • 1. Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia.
    Privitera E; Kamps MP; Hayashi Y; Inaba T; Shapiro LH; Raimondi SC; Behm F; Hendershot L; Carroll AJ; Baltimore D
    Blood; 1992 Apr; 79(7):1781-8. PubMed ID: 1348433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of identical E2A/PBX1 fusion transcripts occurs in both pre-B and early pre-B immunological subtypes of childhood acute lymphoblastic leukemia.
    Izraeli S; Henn T; Strobl H; Ludwig WD; Kovar H; Haas OA; Harbott J; Bartram CR; Gadner H; Lion T
    Leukemia; 1993 Dec; 7(12):2054-6. PubMed ID: 8255105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular variants of the 1;19 chromosomal translocation in pediatric acute lymphoblastic leukemia (ALL).
    Privitera E; Luciano A; Ronchetti D; Aricò M; Santostasi T; Basso G; Biondi A
    Leukemia; 1994 Apr; 8(4):554-9. PubMed ID: 8152250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [E2A gene in t(1;19)-ALL].
    Hayashi Y
    Nihon Rinsho; 1992 Jun; 50(6):1369-73. PubMed ID: 1355570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia.
    Wiemels JL; Leonard BC; Wang Y; Segal MR; Hunger SP; Smith MT; Crouse V; Ma X; Buffler PA; Pine SR
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15101-6. PubMed ID: 12415113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies specific to the acute lymphoblastic leukemia t(1;19)-associated E2A/pbx1 chimeric protein: characterization and diagnostic utility.
    Sang BC; Shi L; Dias P; Liu L; Wei J; Wang ZX; Monell CR; Behm F; Gruenwald S
    Blood; 1997 Apr; 89(8):2909-14. PubMed ID: 9108411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a novel cell line (TS-2) of pre-B acute lymphoblastic leukemia with a t(1;19) not involving the E2A gene.
    Yoshinari M; Imaizumi M; Eguchi M; Ogasawara M; Saito T; Suzuki H; Koizumi Y; Cui Y; Sato A; Saisho T; Ichinohasama R; Matsubara Y; Kamada N; Iinuma K
    Cancer Genet Cytogenet; 1998 Mar; 101(2):95-102. PubMed ID: 9494609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of t(1;19)(q23;p13) acute leukaemias. French Haematological Cytology Group.
    Troussard X; Rimokh R; Valensi F; Leboeuf D; Fenneteau O; Guitard AM; Manel AM; Schillinger F; Leglise C; Brizard A
    Br J Haematol; 1995 Mar; 89(3):516-26. PubMed ID: 7734349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New E2A/PBX1 fusion transcript in a patient with t(1;19)(q23;p13) acute lymphoblastic leukemia.
    Numata S; Kato K; Horibe K
    Leukemia; 1993 Sep; 7(9):1441-4. PubMed ID: 8103813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion with E2A converts the Pbx1 homeodomain protein into a constitutive transcriptional activator in human leukemias carrying the t(1;19) translocation.
    Lu Q; Wright DD; Kamps MP
    Mol Cell Biol; 1994 Jun; 14(6):3938-48. PubMed ID: 7910944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and clinical relevance of genetic abnormalities in pediatric acute lymphoblastic leukemia: a comparison between cytogenetic and polymerase chain reaction analyses.
    Izraeli S; Janssen JW; Haas OA; Harbott J; Brok-Simoni F; Walther JU; Kovar H; Henn T; Ludwig WD; Reiter A
    Leukemia; 1993 May; 7(5):671-8. PubMed ID: 8483319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials.
    Kamps MP; Look AT; Baltimore D
    Genes Dev; 1991 Mar; 5(3):358-68. PubMed ID: 1672117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias.
    Hunger SP; Galili N; Carroll AJ; Crist WM; Link MP; Cleary ML
    Blood; 1991 Feb; 77(4):687-93. PubMed ID: 1671560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pbx1 is converted into a transcriptional activator upon acquiring the N-terminal region of E2A in pre-B-cell acute lymphoblastoid leukemia.
    Van Dijk MA; Voorhoeve PM; Murre C
    Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6061-5. PubMed ID: 8327485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice.
    Kamps MP; Baltimore D
    Mol Cell Biol; 1993 Jan; 13(1):351-7. PubMed ID: 8093327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. t(1;19) without detectable E2A rearrangements in two t(14;18)-positive lymphoma/leukemia cases.
    Wlodarska I; Stul M; De Wolf-Peeters C; Verhoef G; Mecucci C; Cassiman JJ; Van den Berghe H
    Genes Chromosomes Cancer; 1994 Jul; 10(3):171-6. PubMed ID: 7522039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.
    Rambaldi A; Attuati V; Bassan R; Neonato MG; Viero P; Battista R; Di Bona E; Rossi G; Pogliani E; Ruggeri M; Amaru R; Rivolta A; Giudici G; Biondi A; Barbui T
    Leuk Lymphoma; 1996 May; 21(5-6):457-66. PubMed ID: 9172811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia.
    Cayuela JM; Baruchel A; Orange C; Madani A; Auclerc MF; Daniel MT; Schaison G; Sigaux F
    Blood; 1996 Jul; 88(1):302-8. PubMed ID: 8704188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study.
    Borowitz MJ; Hunger SP; Carroll AJ; Shuster JJ; Pullen DJ; Steuber CP; Cleary ML
    Blood; 1993 Aug; 82(4):1086-91. PubMed ID: 8353275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of siRNA-mediated inhibition of E2A-PBX1 on EB-1 and Wnt16b expression in the 697 pre-B leukemia cell line.
    Casagrande G; te Kronnie G; Basso G
    Haematologica; 2006 Jun; 91(6):765-71. PubMed ID: 16769578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.